Investors favor the pharmaceutical sector for its consistent profitability regardless of economic conditions. Additionally, the industry is well-positioned for growth due to the rise in chronic diseases, a rapidly aging population, and the development of drugs for rare conditions.
To that end, it could be wise to buy fundamentally strong pharma stocks: Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ), and AbbVie Inc. (ABBV).
